Results 1 to 10 of about 121,670 (231)

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Diagnosis and Management

open access: yesMedicina (Lithuania), 2021
Stevens–Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are rare diseases that are characterized by widespread epidermal necrosis and sloughing of skin.
Kiran Motaparthi   +2 more
exaly   +2 more sources

A Review of the Systemic Treatment of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis

open access: yesBiomedicines, 2022
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are uncommon but life-threatening diseases mostly caused by drugs. Although various systemic immunomodulating agents have been used, their therapeutic efficacy has been inconsistent ...
Hua-Ching Chang   +2 more
exaly   +2 more sources

Daunorubicin induced Stevens‐Johnson syndrome: A case report

open access: yesClinical Case Reports, 2021
Clinicians should consider the possible association of Daunorubicin with Stevens‐Johnson syndrome (SJS), administer it with caution and promptly evaluate all subsequently developing cutaneous reactions with a high index of suspicion for Stevens‐Johnson ...
Preeti Shakya, Amit Sharma Nepal
doaj   +2 more sources

Stevens-Johnson syndrome

open access: yesJournal of Emergency Medicine, 1984
The clinical manifestations, including variations, of the Stevens-Johnson syndrome (SJS) are reviewed. Lesions of the skin, eye, and mucous membranes are described and discussed. The potential complications and therapeutic approaches are outlined. Finally, the review discusses the controversy over the use of systemic corticosteroids in this syndrome.
OSCAR E Araujo, Franklin P Flowers
exaly   +4 more sources

Nevirapine-induced Stevens–Johnson Syndrome in an HIV-exposed neonate: A case report [PDF]

open access: yesIDCases
A term male infant developed a blistering muco-cutaneous rash in the second week of life following postnatal HIV prophylaxis with nevirapine (NVP). Clinical findings were consistent with Stevens-Johnson syndrome. Following NVP discontinuation, the infant
Eimear M. O’Connell   +3 more
doaj   +2 more sources

Stevens–Johnson syndrome/toxic epidermal necrolysis as the initial presentation of paraneoplastic anti-TIF1-γ dermatomyositis [PDF]

open access: yesSAGE Open Medical Case Reports
We report a rare case of Stevens–Johnson syndrome/toxic epidermal necrolysis as the initial manifestation of paraneoplastic dermatomyositis in a 50-year-old man subsequently diagnosed with diffuse large B cell lymphoma, in the absence of any identifiable
Ghassan Barnawi   +4 more
doaj   +2 more sources

Case Report: Hydronephrosis and nephrogenic adenoma secondary to Stevens-Johnson syndrome [PDF]

open access: yesFrontiers in Pharmacology
IntroductionStevens–Johnson syndrome is a rare, severe cutaneous adverse reaction. There is a lack of literature reporting the complications of the bladder and ureter caused by Stevens–Johnson syndrome.
Chuan Wang, Yidong Huang
doaj   +2 more sources

Stevens‐Johnson Syndrome due to COVID‐19 vaccination

open access: yesClinical Case Reports (discontinued), 2021
As public COVID‐19 vaccination programs are being implemented, it is possible that more rare and serious adverse effects such as Stevens‐Johnson syndrome (SJS) and toxic epidermal necrosis (TEN) may occur.
Nikoo Mozafari
exaly   +2 more sources

UK guidelines for the management of Stevens–Johnson syndrome/toxic epidermal necrolysis in adults 2016

open access: yesJournal of Plastic, Reconstructive and Aesthetic Surgery, 2016
Catherine Smith   +2 more
exaly   +2 more sources

Pembrolizumab-induced Stevens-Johnson syndrome. [PDF]

open access: yesAn Bras Dermatol
de Almeida Junior HL   +5 more
europepmc   +4 more sources

Home - About - Disclaimer - Privacy